MedTrace Logo

Aiming Towards Evidence Based Interpretation of Cardiac Biomarkers in Patients Presenting With Chest Pain

NCT02620202 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 1900

Last updated 2021-04-28

No results posted yet for this study

Summary

The main aim of the WESTCOR study is to

* investigate the ability of two high sensitive cardiac troponin (hs-cTn) assays to diagnose acute coronary syndrome and predict prognosis in different patient populations (e.g. gender, age and co-morbidity)
* to validate the suggested 1 hour protocol for rule in and rule out of acute coronary syndrome for two hs-cTn assays in an unselected chest pain population
* to investigate different biomarkers ability to predict long term prognosis after hospitalization for chest pain

Conditions

  • Acute Coronary Syndrome

Sponsors & Collaborators

  • Helse Stavanger HF

    collaborator OTHER_GOV

  • The Royal Norwegian Ministry of Health

    collaborator OTHER

  • Haukeland University Hospital

    lead OTHER

Principal Investigators

  • Kristin M Aakre, MD, PhD · Laboratory of Clinical Biochemistry, Haukeland University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2020-05-31
Completion
2020-05-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02620202 on ClinicalTrials.gov